Glaucoma is a Oral Liquid in the Human Prescription Drug category. It is labeled and distributed by Newton Laboratories, Inc.. The primary component is Aconitum Napellus; Gold; Atropa Belladonna; Causticum; Cinchona Officinalis Bark; Colchicum Autumnale Bulb; Euphrasia Stricta; Gelsemium Sempervirens Root; Strychnos Nux-vomica Seed; Osmium; Phosphorus; Physostigma Venenosum Seed; Toxicodendron Pubescens Leaf; Spigelia Anthelmia.
| Product ID | 55714-4580_de802f71-3f9a-deab-91dc-a5d2709721b7 |
| NDC | 55714-4580 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Glaucoma |
| Generic Name | Aconitum Nap., Aur. Met., Belladonna, Causticum, Cinchona, Colchicum, Euphrasia, Gelsemium, Nux Vom., Osmium Metallicum, Phosphorus, Physostigma, Rhus Toxicodendron, Spigelia Anth. |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-06-01 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
| Labeler Name | Newton Laboratories, Inc. |
| Substance Name | ACONITUM NAPELLUS; GOLD; ATROPA BELLADONNA; CAUSTICUM; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; STRYCHNOS NUX-VOMICA SEED; OSMIUM; PHOSPHORUS; PHYSOSTIGMA VENENOSUM SEED; TOXICODENDRON PUBESCENS LEAF; SPIGELIA ANTHELMIA |
| Active Ingredient Strength | 15 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
| Pharm Classes | Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Allergens [CS],Cell-mediated Immunity [PE],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [CS],Plant Proteins [CS],Seed Storage Proteins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2011-06-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-02-10 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-06-01 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| ACONITUM NAPELLUS | 15 [hp_X]/mL |
| SPL SET ID: | 920158ec-fee7-5e2b-0bcd-e56d3d0effde |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 55714-4580 | Glaucoma | Aconitum nap., Aur. met., Belladonna, Causticum, Cinchona, Colchicum, Euphrasia, Gelsemium, Nux vom., Osmium metallicum, Phosphorus, Physostigma, Rhus toxicodendron, Spigelia anth. |
| 55714-4581 | Glaucoma | Aconitum nap., Aur. met., Belladonna, Causticum, Cinchona, Colchicum, Euphrasia, Gelsemium, Nux vom., Osmium metallicum, Phosphorus, Physostigma, Rhus toxicodendron, Spigelia anth. |
| 68770-220 | Glaucoma | arnica montana, gelsemium sempervirens, lycopodium clavatum, phosphorus, physostigma venenosum |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() GLAUCOMA 73163222 1140329 Dead/Cancelled |
AMERICAN SOCIETY OF CONTEMPORARYMEDICINE, SURGERY & OPTHALMOLOGY 1978-03-22 |